BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2001
View Archived Issues
Uprima/Ixense for ED given positive opinion by CPMP
Read More
Year 2000 progress highlighted by Sepracor
Read More
Trimeris and Roche report clinical results for T-20 and T-1249
Read More
YM BioSciences and SR Pharma to codevelop cancer vaccine
Read More
Vasogen prepares Canadian trial of VAS-972 for psoriasis
Read More
Bavarian Nordic licenses vaccine technology
Read More
Chinese herbal formulation undergoes evaluation for anti-HIV, immune and cardiovascular effects
Read More
BSF-302146 may have potential for preventing restenosis following CABG surgery
Read More
F-12511: a potent ACAT inhibitor with cholesterol-lowering and antiatherosclerotic effects
Read More
Ark Therapeutics emerges as major European gene-based company
Read More
Product developments announced by Forest
Read More
Aventis and Novo Nordisk sign license agreement and end Lantus litigation
Read More
Clearance sought to begin clinical trials with INS-37217 Ophthalmic
Read More
ImaRx and Elan establish joint venture for HydroPlex drug delivery system
Read More
Sibutramine maintains significant weight loss over two years in the STORM study
Read More
Dimethaid begins mutual recognition procedure in E.U. for Pennsaid
Read More
SafeScience gains additional patent rights to GBC-590
Read More
Theratechnologies' ex vivo PDT cell therapy system enters clinical testing
Read More
Tanox updates product developments, looks ahead to 2001
Read More
Venlafaxine for the management of hot flashes in menopausal women
Read More
Selective beta2-adrenoceptor agonists and therapeutic use described by Novartis
Read More
Merck presents novel substituted piperidines as selective human MC4 receptor agonists
Read More
New MMP-inhibitory hydroxamic acid derivatives and use thereof
Read More
Thiophene integrin inhibitors designed at BioChem Pharma
Read More
Immunomodulating imidazoquinolines a focus of R&D at 3M Innovative Properties
Read More
Merck continues to investigate new chemokine receptor modulators
Read More